Pulmotect, Inc. Press Releases

• Published on September 17, 2024 - 16:26 GMT

  Pulmotect Raises $5.9M Series C Round Led by Fannin Partners

  Funding led by Fannin Partners with participation by Axil Capital provides support for the Company’s Phase 2 Anti-Viral Trial and further development of PUL-042 HOUSTON, TX, UNITED STATES, September 17, 2024 /⁨EINPresswire.com⁩/ -- Pulmotect, Inc., a …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on May 30, 2023 - 15:00 GMT

  Pulmotect Awarded $8.9 Million from The State of Texas

  Funding from the Cancer Prevention and Research Institute of Texas will support development for Phase 2 Anti-Viral Trial and further development of PUL-042 HOUSTON, TEXAS , UNITED STATES, May 30, 2023 /⁨EINPresswire.com⁩/ -- Houston, TX (May 30, 2023) – …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...